SCHEMBL7147019

SCHEMBL7147019

CCCCC(CC)CNC1CCN([S+]([O-])c2ccc(CNC(=O)c3ccc(Cl)cc3)s2)C1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 2/20 0.37
TP53 P04637 4/20 0.35
MAPK9 P45984 1/20 0.34
MAPK10 P53779 1/20 0.34
PRMT5 O14744 4/20 0.33
MAPT P10636 1/20 0.33
CCR2 P41597 1/20 0.33
GLA P06280 1/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
EPHX2 P34913 1/20 0.32
PPARG P37231 1/20 0.32
NR1D1 P20393 1/20 0.32
MAP4K1 Q92918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138046 0.94 KDM4E (0.38) SMN1; SMN2KDM4EALDH1A1TSHRTP53
SCHEMBL7144053 0.82 GAA (0.40) ALDH1A1TSHRTP53MAPTEPHX2
SCHEMBL3479817 0.81 MAPK9 (0.53) SMN1; SMN2KDM4EALDH1A1TSHRTP53
SCHEMBL3479811 0.81 MAPK9 (0.51) SMN1; SMN2KDM4EALDH1A1TSHRTP53
SCHEMBL7145126 0.80 GAA (0.38) ALDH1A1TSHRTP53MAPTEPHX2
SCHEMBL7139566 0.79 KDM4E (0.42) SMN1; SMN2KDM4EALDH1A1MAPK9MAPK10
SCHEMBL7142563 0.79 TP53 (0.44) SMN1; SMN2KDM4EALDH1A1TP53MAPT
SCHEMBL3479765 0.79 MAPK9 (0.51) SMN1; SMN2KDM4EALDH1A1TSHRMAPK9
SCHEMBL7139807 0.76 DRD2 (0.38) SMN1; SMN2KDM4EALDH1A1TP53MAPK9
SCHEMBL7146530 0.76 KDM4E (0.45) SMN1; SMN2KDM4EALDH1A1TP53MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322642-A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES Applied Research Systems ARS Holding N.V. (AN) 2003-07-02 EP disclosed
WO-2002026733-A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2002-04-04 WO disclosed